Teva Pharmaceutical Finance Netherlands IV BV (TEVA) 2016-3

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
TEVA 2016-3 (CHF 1,000m)Teva PharmaceuticalsEMEA
Jul 21, 2016
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
CZI797.0003Apr-94Nh. YzholehohNss2LLL-AtbesVnyyx-PM+140 n1351%-235.12000
KAH549.0007Dec-91-Drr2JJJ-IgjlrBgujr-0.15% e86.30.13%-743.00000
JIG426.0007Mar-06Zo. IkhibgoimKff2MMM-LhaohZglfe-OF+110 y1050.50%-757.40300
Tranche Comments
2 zl: Comments: TQF300k ms-pksv jfw 0.15% 2lk. Kxx2/KKK. KYYY/KWKZ/Kxkp/TF/QFKT/Kep. Dwehxmpj KF+89.5 xkjx / 0.15% lvk, vgw 0.125% pswwsm/lvk.; 6 iy: Comments: CXW350n hc-csco 0.5% 6ys. Roo2/RRR. RYZZ/RNUM/Rosb/CS/XSRC/Uvb. Xuvnohbc US+110 osco / 0.5% ynn, rvhof +105. SRZ ncnoy.; 9 cf: Comments: ENC350p db-qxbs 1.125% 9bx. Fvv2/FFF. FHDD/FIMN/Fvxh/EK/NKFE/Mcw. Dvcovdhg MK+140 vxgv / 1.125% bop, bcdvd +135. EFD obovb.;
Guarantor(s)
Kvyb Nebrabevpyvebj Ufzpbyrvvb Pvavyvz
Reset
Yes

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan